By Dr. Shuang Chen, Ph.D. Senior Principal Scientist, AbbVie In recent years, more and more structurally diverse and complex molecules have been developed to tackle difficult but attractive drug...
Shuang Chen is currently a Senior Principal Scientist in Small Molecule CMC Development organization at AbbVie. He has over 18 years of pharmaceutical development experience with specialties in molecular...
Dr. Noalle Fellah is a Senior Scientist in the Crystallization Technology Lab (CTL) within Chemical Research and Development (CRD) at Pfizer, Inc. Noalle earned her PhD in Chemistry from...
By Dr. James D. Fostinis, Ph.D. Drug Substance Technologies Engineer, Amgen Quench crystallization approaches provide unique opportunities to design and control crystallization of pharmaceutically-relevant compounds, which can help streamline...
Jim Fostinis is an Engineer within the Drug Substance Technologies – Synthetics team in Process Development at Amgen. During his time at Amgen, Jim has focused on small molecule...
By Prof. Jerry Heng, Ph.D. Professor, Department of Chemical Engineering at Imperial College The purification of high molecular weight new modalities such as peptides, for their use in biopharmaceutical...
Jerry Heng (JH) is currently a Professor in Particle Technology and Director of UG Studies at the Department of Chemical Engineering at Imperial College London. JH obtained his PhD in Chemical Engineering from...
By Dr. Gerard Capellades, Assistant Professor, Rowan University Industrial crystallization is heavily used as a purification step and to isolate valuable products with the desired solid-state properties. Consequently,...
Gerard Capellades is an Assistant Professor at Rowan University’s Department of Chemical Engineering. He has worked on crystallization as his primary research field for the past 12 years, always...
